top of page
  • Writer's pictureJohn Q Leonard

Roche buys dX company for $1B

Updated: Mar 17, 2020

Diagnostics was once the red-headed step child of our industry. Therapeutics was where all the excitement was, and the money to boot. After all, it's much more exciting to cure diseases than to simply tell folks if they are sick or well.

Exit "personalized medicine" and Enter "precision medicine."

Well that all appears to have changed for several reasons. Right now, it's a great time to be in cancer diagnostics.

29 views0 comments

Recent Posts

See All
bottom of page